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On the qualitative analysis of the uniqueness of the movement of
endothelial cells
Erdem Altuntaç and Serdal Pamuk

Abstract
This paper extends the work of Pamuk (2003) by showing mathematically that the movement of endothelial cells, to the regions where active enzyme is large or where ﬁbronectin is small, is unique. To do this, we
obtain the existence and uniqueness of the steady-state solution of an initial-boundary value problem which
mathematically models endothelial cell movement in tumor angiogenesis. A speciﬁc example showing the
instability of this steady-state solution is provided.
Key Words: Existence; uniqueness; tumor angiogenesis; steady-state solution; transition probability
density function.

1.

Introduction

Angiogenesis is a morphogenic process whereby new blood vessels are induced to grow out of a pre-existing
vasculature. It is essential for tumor progression and is critical for the growth of primary cancer. It is well known
that it occurs in three sequential steps [13]. First, the endothelial cell (EC) lining the vascular basal lamina
(BL) (or basement membrane) degrade this membrane. Second, the EC migrate and proliferate (via mitosis)
into the extra cellular matrix (ECM). Finally, capillary loops form. In recent years, progress has been made
to understand this phenomenon at the molecular level. This includes the identiﬁcation of potent angiogenic
factors, the discovery of the role of proteases, the importance of the ECM, and the emerging characterization
of signal transduction pathways in EC.
One of the major components of the ECM is ﬁbronectin, a large, highly adhesive glycoprotein particularly
abundant in plasma, connective tissue matrices, and BL [8]. It is also known to enhance EC adhesion to collagen
and is produced by EC. The simplest unifying interpretation of these ﬁndings is that it functions as adhesive
proteins that bind cells to other cells or to a substrate. Fibronectin-treated cells also migrate more rapidly,
both as single cells or as masses of cells migrating out from cell aggregates [14].
As stated in [4] and [5] EC are to be stimulated by a tumor angiogenic factor for angiogenesis to occur.
After the EC are stimulated they will follow the trail of transition probability density function of active enzyme
and ﬁbronectin (TPDF) (see also [11]).
2000 AMS Mathematics Subject Classiﬁcation: .
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There have been many mathematical models describing tumor angiogenesis such as the models in Refs.
[1], [7], [10]–[12]. Also, mathematical analyses on the foundations of cancer modeling have been presented in
some of these studies. For example, in [11] the Author proves mathematically that the long-time tendency of
EC governed by the model equation originally developed in [7] is toward TPDF, and shows that the steady-state
solution of the equation is, in fact, stable. Similarly, a steady-state analysis of the two dimensional version of
the same model in the absence of tumor source is given in [12].
The main aim of this paper is to extend the work done in [11] by showing mathematically that the
tendency of EC to the TPDF is unique; i.e., we want to show that the movement of EC, into the regions where
active enzyme is large or where ﬁbronectin is small, is unique. To do this, the existence and uniqueness of
the steady-state solution of an initial-boundary value problem which mathematically models EC movement in
tumor angiogenesis are obtained using the Lax-Milgram Theorem.
The layout of the remainder of this paper is as follows: in Section 2 we describe our modeling assumptions,
and write down our one dimensional model equations originally presented in [7]. In Section 3, we provide a
mathematical analysis to obtain the existence and uniqueness of the steady-state solution of the model. In section
4, we introduce a speciﬁc example for our model by choosing TPDF that has a non-unimodal distribution form,
and observe that the steady-state solution of the model is, in fact, instable. Finally, we close the paper by
presenting the conclusions and the discussions on the biological importance of our results.

2.

Modeling assumptions
We envisage a capillary segment of length l microns located along the x axis, and rescale x by x/l so

that we have 0 ≤ x ≤ 1 . Also, we make the following assumptions on the biochemistry of angiogenesis and its
inhibition [11].
V denotes a molecule of angiogenic factor (substrate) and RE denotes a receptor on the EC wall; they
combine to produce an intermediate complex, RE V which is an activated state of the receptor that results in
the production and secretion of proteolytic enzyme, C and a modiﬁed intermediate receptor RE . The receptor
RE is subsequently removed from the surface by a mechanism that is presumed to be very fast in the time
scale of the production of protease C . The receptor RE is then either recycled back to the cell surface to again
become RE or it is degraded and new RE is synthesized, which then moves to the cell surface to replace the
RE that had been removed.
The point of view is that the receptors at the surface of the cell function in the same way as an enzyme
functions in classical enzymatic catalysis. In symbols:




V + RE  RE V

→ C + RE .

(2.1)

Here we consider angiostatin stimulates EC to produce an inhibitor I according to the mechanism



A + REA
CA + I
368



AREA → I + REA ,

 CI ,

(2.2)
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where REA is a receptor protein on the endothelial cell wall and [AREA ] is the intermediate complex. Moreover,
A is angiostatin and I is a protease inhibitor produced by the endothelial cells in response to the angiostatic
agent by an overall mechanism which we will assume to be of Michaelis-Menten type. Here CI denotes the
proteolytic enzyme molecules that are inhibited by the inhibitor I from functioning as a catalyst for ﬁbronectin
degradation while CA denotes those molecules, which degrade ﬁbronectin. In terms of concentrations, [C] =
[CA ] + [CI]. Assuming that the reaction in the second equation of (2.2) is in equilibrium, we have that
[CI] = νe [I][CA] , where νe is the equilibrium constant for this step. In general, the larger νe is, the more
eﬃcacious the angiostatin will be in the inhibition of angiogenesis.
The decay of ﬁbronectin F via protease is assumed to satisfy a reaction mechanism of the form


CA + F  CA F → CA + F  ,

(2.3)

which shows that CA acts as a catalyst to convert the ﬁbronectin into products F  .
We use the following notation for the concentrations of the various chemical species along the capillary
wall in units of μM (micro moles per cubic liter):
v(x, t) =

angiogenic factor,

c(x, t) =

proteolytic enzyme,

ca (x, t) =

active proteolytic enzyme,

ci (x, t) =

inhibited proteolytic enzyme,

ia (y, t)

=

protease inhibitor,

f(x, t)

=

ﬁbronectin,

a(x, t) =

angiostatin,

u(x, t) =

endothelial cell density,

where t indicates the time variable. If we now apply the law of mass action to the equations (2.1)–(2.3) (see [7]
for details), which asserts that the rate of reaction is proportional to the product of the concentrations of the
reactants, we obtain the following system of equations:

∂v
∂t

=

∂c
∂t

=

∂f
∂t

=

∂a
∂t

=

−

λ1 v u
+ vr (x, t),
1 + ν 1 v u0

λ1 v u
− μc,
1 + ν 1 v u0


f u
λ3 ca f
4
f 1−
−
,
Tf
f0 u0
1 + ν3 f
−

λ2 a u
+ ar (x, t),
1 + ν 2 a u0
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∂ιa
∂t

=

λ2 au
ιa (x, t)
,
−
1 + ν2 a
Trel

c =

ci + ca ,

ci

ν e ι a ca ,

=

(2.4)

where λi , νi (i = 1, 2, 3) are kinetic parameters, u0 , f0 are some reference numbers for EC and ﬁbronectin,
respectively, Tf is ﬁbronectin generation time, Trel is angiostatin relaxation time, vr is the rate at which
growth factor is being supplied to the capillary from the tumor and ar , the source term for angiostatin, will be
taken to be constant in the therapeutic case.
Furthermore, if we use the theory of reinforced random walk [2], we obtain the EC movement equation
(see [7] for the derivation of the following equation) as follows
∂u
∂t

= D




∂
∂
u
u
ln
.
∂x
∂x
τ̂

(2.5)

Here, u = u(x, t) is the concentration of EC in the capillary wall. D is the EC diﬀusion coeﬃcient, which we
think it is probably a safe assumption to take as a positive constant in the vessel wall. However, in the ECM
itself, it is probably anything but constant. Also, τ̂ is the so called TPDF [9]. This function has the eﬀect
of biasing the random walk of EC. In this case, we know that the walk is inﬂuenced by the active proteolytic
enzyme it produces in response to the angiogenic factor that has made its way to the cell receptors, and by the
ﬁbronectin in the BL, thus, we write
τ̂

=

τ̂ (ca , f).

A simple transition probability which reﬂects the inﬂuence of active enzyme and ﬁbronectin on the motion
of EC is τ̂ (ca , f) = cγa1 f −γ2 for positive constants γi (i = 1, 2) [7].
The biological interpretation of this choice is that EC prefer to move into the regions where ca is large or where
f is small.
In order to avoid singularities in ln τ̂ and its derivatives in (2.5), it is useful to take τ̂ (ca , f) = τ1 (ca )τ2 (f) where

τ1 (ca ) =

a 1 + ca
a 2 + ca

γ1


, τ2 (f) =

b1 + f
b2 + f

γ2
.

Here the ai , bi are constants such that 0 < a1 << 1 < a2 and b1 > 1 >> b2 > 0. Clearly, τ̂ is not singular for
small or large values of ca , f and will approximate cγa1 f −γ2 over a considerable range of these variables [7]. We
impose zero ﬂux boundary conditions for the cells in the capillary

Du



∂
u
ln
=
∂x
τ̂ (ca , f)

0,

(at x = 0, 1),

(2.6)

and take u(x, 0) = u0 > 0 , since we assume that the capillary is initially in a rest state. As made in [11],
we also assume here that the active enzyme ca and ﬁbronectin f are time-independent. Therefore, we let
370
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τ̂ (ca (x), f(x)) := κ(x), and u0 = 1 for simplicity, and consider the initial-boundary value problem
∂u
∂
=D
∂t
∂x



∂
u
∂x



u
ln
κ (x)


, (x, t) ∈ ΩT := (0, 1) × (0, T ],

u(x, 0) = 1 , x ∈ (0, 1),


∂
u
Du
ln
= 0 , (at x = 0, 1), t ∈ (0, T ],
∂x
κ (x)

(2.7)

which has been studied numerically in [10]. Here, T is a positive real number.
The right hand side of the ﬁrst equation of (2.7) can be written
∂
D
∂x

where F (x) :=

 


∂
u
u
ln
= D (uxx − (uF (x))x) ,
∂x
κ(x)

κ (x)
. Therefore, our original problem becomes
κ(x)
ut = D(uxx − (uF (x))x ) , (x, t) ∈ ΩT ,
u(x, 0) = 1 , x ∈ (0, 1),
ux (x, t) = uF (x) , (at x = 0, 1), t ∈ (0, T ].

(2.8)

Throughout the paper we assume functions ca (x) and f(x) have unimodal distribution forms (as made
in [7] and [11]) with the conditions ca (0) = ca (1) = 0 and f  (0) = f  (1) = 0 . This implies that we actually
assume κ (0) = κ (1) = 0. Therefore, one obtains F (0) = F (1) = 0 , so that the boundary conditions given by
the last equation of (2.8) become ux (x, t) = 0 at x = 0, 1 .

3.

Existence and uniqueness of the steady-state solution
Since our aim is to investigate the existence and uniqueness of the steady-state solution of (2.8), we

consider the following two-point boundary value problem (time- independent problem) with homogeneous
Neumann boundary data
−

d2 u
d
+
(uF (x)) = 0 , x ∈ (0, 1),
dx2
dx
u (0) = u (1) = 0.

(3.1)

It is well-known that whenever F (x) ∈ C 1 [0, 1] boundary value problem (3.1) possesses a unique classical
solution, u(x) ∈ C 2 (0, 1), which satisﬁes (3.1) for every x ∈ [0, 1] . We are interested in a generalized solution of
(3.1); i.e., a function u(x) that satisﬁes (3.1) in some sense when F (x) is not continuous; if F (x) is suﬃciently
smooth then we want the generalized solution to coincide with the classical solution. In the sequel, we shall
assume that F  (x) is measurable, bounded function on [0,1] satisfying 0 < K1 ≤ F  (x) ≤ K2 for all x ∈ [0, 1] ,
where K1 and K2 are constants.
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We will now construct a framework to pose certain weak formulations, and then state the Lax-Milgram
theorem which will guarantee the existence and uniqueness of the solution of our weak formulation of the
problem (3.1). To this end, we seek u ∈ H satisfying a(u, v) = g(v) for all v ∈ H, where H is a Hilbert space,
a(., .) is a bilinear form on H, and g is a bounded linear functional on H. The following theorem presents
conditions which guarantee the existence and uniqueness of its solution. The result requires that the bilinear
form be bounded on the space H; in addition, it requires that the bilinear form have the property, which is
referred to as coercivity given in (3.3) below.
Theorem 3.1 (Lax-Milgram Theorem) Let H be a Hilbert space and let a(., .) : H × H → R1 be a
bilinear form on H which satisﬁes
|a(u, v)| ≤ C||u||||v||

for all

u, v ∈ H

(3.2)

and
a(u, v) ≥ N ||u||2

for all

u ∈ H,

(3.3)

where C and N are positive constants independent of u, v ∈ H. Let g : H → R1 be a bounded linear
functional on H. Then there exists a unique u ∈ H satisfying a(u, v) = g(v) for all v ∈ H [6].
Deﬁnition 3.1 (Sobolev Spaces) The Sobolev space H m (Ω) is the set of functions u ∈ L2 (Ω) which
possess generalized (weak) L2 -derivatives Dα u which are also in L2 (Ω) for 0 ≤ |α| ≤ m [6]; i.e.,
H m (Ω) = {u ∈ L2 (Ω) : Dα u ∈ L2 (Ω) for 0 ≤ |α| ≤ m}.

(3.4)

Clearly, H m (Ω) is a subspace of functions L2 (Ω) and H 0 (Ω) = L2 (Ω). On H m (Ω) we deﬁne the inner product
(u, v)m =

 

Dα uDα vdx =

|α|≤m Ω



(Dα u, Dα v)

for all

u, v ∈ H m (Ω),

(3.5)

|α|≤m

where (., .) denotes the standard inner product on L2 (Ω). Using this deﬁnition of inner product, we deﬁne the
norm on H m (Ω) [6] as
⎛
⎝
||u||m = (u, u)1/2
m =



⎞1/2
||Dα u||2⎠

for all

u ∈ H m (Ω),

(3.6)

|α|≤m

where ||.|| denotes the standard norm on L2 (Ω). Clearly, ||.||0 = ||.|| .
We have Ω = (0, 1) ⊂ R1 for our problem (3.1), so that Dα denotes the ordinary diﬀerential operator.
Also, our underlying ﬁnite element space is H 1 (0, 1), and the bounded linear functional g is the zero functional.
The weak formulation is therefore to ﬁnd u ∈ H 1 (0, 1) which satisﬁes
a(u, v) = 0

for all

v ∈ H 1 (0, 1),

(3.7)

where

a(u, v) =
0
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(2u v + F  (x)uv)dx

for all

u, v ∈ H 1 (0, 1).

(3.8)
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Using the deﬁnition of a(u, v) and the Cauchy-Schwartz inequality, we have for u, v ∈ H 1 (0, 1)

|a(u, v)| ≤ 2

1



|u ||v |dx + K2

0

1

|u||v|dx ≤ 2||u||||v || + K2 ||u||||v||.

0

We now use the deﬁnition of the L2 - and H 1 - norms, and have that
|a(u, v)| ≤ 2||u||1||v||1 + K2 ||u||1||v||1 ≤ C||u||1||v||1,
where C = 2max(2, K2 ). Therefore, condition (3.2) of the Lax-Milgram theorem is satisﬁed. Now, for u ∈
H 1 (0, 1),

a(u, u) = 2

1

(u )2 dx +

0



1

F  (x)u2 dx ≥ 2||u||2 + K1 ||u||2.

0

Again, from the deﬁnition of the L2 - and H 1 - norms one has
a(u, u) ≥ N ||u||21,
where N = min(2, K1 ). This shows the condition (3.3) of the Lax-Milgram theorem is met. Thus we are
guaranteed the existence and uniqueness of a solution to (3.7).
On the other hand, it is easy to see that if we integrate the ordinary diﬀerential equation given in (3.1)
with respect to x , we obtain
du
− uF (x) = C,
dx
where C is a constant. Applying the boundary conditions given in (3.1) gives C = 0 , and hence,
du
κ (x)
= uF (x) = u
.
dx
κ(x)

(3.9)

Solving this simple diﬀerential equation gives
u = u(x) = Aκ(x),

(3.10)

where A is a positive constant of integration chosen to ensure conservation of EC. In fact, if we recall the
deﬁnition of κ(x), we have
γ 
γ

a1 + ca (x) 1 b1 + f(x) 2
,
u(x) = A
a2 + ca (x)
b2 + f(x)

(3.11)

where ca (x), f(x), a1 , a2 , γ1 , b1 , b2 , γ2 are the same as in Section 2. Also, in [11] the Author has shown mathematically that u(x, t) → Aκ(x) as t → ∞ , where u(x, t) is the solution of (2.8). This, in fact, shows that the
steady-state solution obtained in (3.10) is stable.
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4.

A speciﬁc example
In the last part of Section 2 we emphasized that we must have κ (0) = κ (1) = 0 for our TPDF, κ(x). As

a counter example, we choose κ(x) = Cex , which clearly does not have these properties. Here C is a positive
constant. In this case, the initial-boundary value problem (2.8) becomes
ut = Duxx − aux

, (x, t) ∈ ΩT ,

u(x, 0) = 1 , x ∈ (0, 1),
ux(x, t) = 0 , (at x = 0, 1), t ∈ (0, T ],

(4.1)

where a = CD . After a somewhat tedious computations [3], one obtains that u(x, t) ≡ 1 is the unique solution
of the problem (4.1). Therefore, as t → ∞ , we have
u(x, t) → 1 = Cex = κ(x),

(4.2)

which shows that the solution is instable.

5.

Conclusions and discussion

In this paper we have presented a qualitative analysis on the uniqueness of the movement of EC in tumor
angiogenesis. To do this, we have obtained the existence and uniqueness of the steady-state solution of an
initial-boundary value problem which models EC movement. The analysis is based on the assumption that
active enzyme ca (x, t), and ﬁbronectin f(x, t) are time-independent, i.e., they are in quasi-steady state.
The steady-state solution obtained in (3.11) is dependent on the magnitude of sensitivity parameters
ai , bi , γi , (i = 1, 2). In [7], the inﬂuence of these sensitivity parameters on ﬁbronectin channel opening is
discussed, and shown that the larger the transition probability sensitivity factors (i.e, the more sensitive EC
movement is to gradients in protease and in ﬁbronectin), the more quickly they gather in the opening of the
lumen which is created by the protease.
Since the endothelial cell equation we have here is derived as the continuous limit of a reinforced random
walk [9], the transition probability function, κ(x) provides the link between microscopic and macroscopic events.
Our choice for it, therefore, reﬂects the known facts that EC movement depends not only upon protease and
ﬁbronectin gradients but also upon their concentrations.
On the other hand, in [11] the Author has shown mathematically that the long-time tendency of EC is
toward the TPDF, κ(x), i.e., he has proved that u(x, t) → Bκ(x) as t → ∞ , where B is a positive constant.
Biologically, this can be interpreted as follows. When EC equation is thought of as a diﬀusion process for a
reinforced random walk, the long time tendency for such a process will be to drive u in such a way as to bring
the ratio u/κ to unity. In other words, the “walker density equation” asserts that the walker will move in
such a way as to have a large probability density where the transition probability rate is large, and a small
probability density where it is small. Recalling our choice for κ, it means that EC move into the regions where
active enzyme is large or where ﬁbronectin is small. According to our results in Section 3, the steady-state
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solution given in (3.10)–(3.11) is the unique solution of the boundary value problem (3.1), which shows that
this movement of EC into such regions is, in fact, unique.
Also, combining the result obtained in [11] with the result we have obtained in (3.10), one can conclude
that the steady-state solution u(x) of the problem (2.8) is stable with κ(x) has the form deﬁned in Section
2 (i.e, κ(x) has unimodal distribution form). In Section 4, we have provided a speciﬁc example by choosing
κ(x) that has a non-unimodal distribution form. In this case, the result obtained in (4.2) indicates that the
steady-state solution is, in fact, instable. As a result, one has to have a unimodal distribution form of TPDF
in order to have a stable movement of EC.
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